Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. S-1 Offering Registration Statement
  4. DRS/A Other Draft Registration Statement
  5. UPLOAD Other SEC-generated Letter
  6. DRSLTR Other Correspondence Related to Draft Registration Statement
  7. DRS/A Other Draft Registration Statement
  8. UPLOAD Other SEC-generated Letter
  9. DRS Other Draft Registration Statement

Page 40 of 40 · 789 filings